NO20044979L - Nye biomaterialer, deres fremstilling og anvendelse - Google Patents
Nye biomaterialer, deres fremstilling og anvendelseInfo
- Publication number
- NO20044979L NO20044979L NO20044979A NO20044979A NO20044979L NO 20044979 L NO20044979 L NO 20044979L NO 20044979 A NO20044979 A NO 20044979A NO 20044979 A NO20044979 A NO 20044979A NO 20044979 L NO20044979 L NO 20044979L
- Authority
- NO
- Norway
- Prior art keywords
- precipitate
- components
- additional
- component
- amphilic
- Prior art date
Links
- 239000012620 biological material Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002244 precipitate Substances 0.000 abstract 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 2
- 229920006318 anionic polymer Polymers 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000003905 agrochemical Substances 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000575 pesticide Substances 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02008809 | 2002-04-19 | ||
PCT/EP2003/004076 WO2003089008A1 (en) | 2002-04-19 | 2003-04-17 | Novel biomaterials, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044979L true NO20044979L (no) | 2004-11-16 |
Family
ID=29225593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044979A NO20044979L (no) | 2002-04-19 | 2004-11-16 | Nye biomaterialer, deres fremstilling og anvendelse |
Country Status (20)
Country | Link |
---|---|
US (3) | US20050163853A1 (pt) |
EP (1) | EP1499361B1 (pt) |
JP (1) | JP4648632B2 (pt) |
KR (1) | KR101121675B1 (pt) |
CN (1) | CN1646171B (pt) |
AU (1) | AU2003224099B2 (pt) |
BR (1) | BR0309340A (pt) |
CA (1) | CA2484100C (pt) |
CO (1) | CO5611168A2 (pt) |
ES (1) | ES2392964T3 (pt) |
HK (1) | HK1073070A1 (pt) |
IL (1) | IL164627A (pt) |
MX (1) | MXPA04010325A (pt) |
NO (1) | NO20044979L (pt) |
NZ (1) | NZ535810A (pt) |
PL (1) | PL215579B1 (pt) |
PT (1) | PT1499361E (pt) |
RU (1) | RU2321597C2 (pt) |
WO (1) | WO2003089008A1 (pt) |
ZA (1) | ZA200407794B (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
AU2005209201B2 (en) * | 2004-01-20 | 2010-06-03 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
WO2006011044A1 (en) * | 2004-07-22 | 2006-02-02 | Pfizer Products Inc. | Amorphous cyclodextrin compositions |
US20060089590A1 (en) * | 2004-10-27 | 2006-04-27 | John Higuchi | Methods and devices for sustained in-vivo release of an active agent |
EP1787658B1 (en) | 2005-11-10 | 2012-03-14 | CHEMI S.p.A. | Sustained release formulations of somatostatin analogue inhibitors of growth hormone |
CN101501484B (zh) * | 2006-09-04 | 2012-12-26 | 独立行政法人产业技术综合研究所 | 通过毛细管电泳法分析试样的方法 |
JP2009186445A (ja) * | 2008-02-08 | 2009-08-20 | Arkray Inc | キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬 |
US8137512B2 (en) * | 2006-09-04 | 2012-03-20 | National Institute Of Advanced Industrial Science And Technology | Process for analyzing sample by capillary electrophoresis method |
US20100155242A1 (en) * | 2006-09-04 | 2010-06-24 | Arkray, Inc. | Method of Analyzing a Sample by Capillary Electrophoresis |
CN102421451B (zh) | 2009-02-25 | 2013-11-06 | 休普拉特克药品有限公司 | 苯达莫司汀环多糖组合物 |
US8389558B2 (en) * | 2009-07-20 | 2013-03-05 | Supratek Pharma Inc. | Bendamustine amphiphilic anionic compositions |
US20110015245A1 (en) * | 2009-07-20 | 2011-01-20 | Valery Alakhov | Bendamustine amphiphilic cationic compositions |
EP2547221B1 (en) | 2010-03-13 | 2014-12-17 | Eastpond Laboratories Limited | Fat-binding compositions |
US8383663B2 (en) | 2010-07-19 | 2013-02-26 | Supratek Pharma Inc. | Bendamustine anionic-catioinic cyclopolysaccharide compositions |
JP2014502612A (ja) | 2010-12-31 | 2014-02-03 | イーストポンド・ラボラトリーズ・リミテッド | シクロデキストリンを含有する細胞水和組成物 |
US20120171184A1 (en) | 2010-12-31 | 2012-07-05 | Lajos Szente | Cellular hydration compositions |
BR112013018933A2 (pt) * | 2011-02-10 | 2016-09-13 | Unilever Nv | composições antiviral, antisséptica líquida, e sólida para a lavagem pessoal, de limpeza sólida e líquida da superfície rígida, antimicrobiana, higienizadora de mãos, método de desinfecção de uma superfície e utilização de uma composição |
EP2804915B1 (en) | 2012-01-18 | 2016-03-30 | SurModics, Inc. | Lubricious medical device coating with low particulates |
CA2932532C (en) * | 2012-12-04 | 2021-06-22 | Phosphorex, Inc. | Microparticles and nanoparticles having negative surface charges |
US20160096931A1 (en) * | 2013-05-17 | 2016-04-07 | Marquette University | Composite materials containing structural polysaccharides and macrocyclic compounds formed from ionic liquid compositions |
JP5673756B2 (ja) * | 2013-08-20 | 2015-02-18 | 東洋紡株式会社 | 医療用材料 |
RU2597085C2 (ru) * | 2013-11-07 | 2016-09-10 | Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) | Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты) |
US20180369124A1 (en) | 2015-06-24 | 2018-12-27 | Kao Germany Gmbh | Hair treatment process |
US10342898B2 (en) * | 2015-12-29 | 2019-07-09 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US11174447B2 (en) | 2015-12-29 | 2021-11-16 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
WO2018075614A1 (en) | 2016-10-18 | 2018-04-26 | Marquette University | Composite materials containing structural polymers and photoreactive nitric odide releasing agents and uses thereof for wound dressings |
EP4132294A1 (en) | 2020-04-06 | 2023-02-15 | Eastpond Laboratories Limited | Compositions for promoting cellular hydration |
CN114344557A (zh) * | 2022-01-10 | 2022-04-15 | 山东万容生物科技有限公司 | 一种含环糊精的水胶体敷料及其制备方法 |
WO2023212740A1 (en) * | 2022-04-29 | 2023-11-02 | Drexel University | Surfactant-impregnated mof-coated fabric for antimicrobial applications |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE670837A (pt) * | 1964-10-14 | 1966-01-31 | ||
JPS61251616A (ja) * | 1985-04-30 | 1986-11-08 | Agency Of Ind Science & Technol | 溶質の放出量の制御方法 |
JPS6416728A (en) * | 1987-07-07 | 1989-01-20 | Santen Pharmaceutical Co Ltd | Aqueous preparation |
JPH03234770A (ja) * | 1990-02-09 | 1991-10-18 | Nippon Shokubai Kagaku Kogyo Co Ltd | 電気刺激応答性ゲルの製法 |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5464650A (en) * | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
SE9303627D0 (sv) * | 1993-11-03 | 1993-11-03 | Kabi Pharmacia Ab | Method and means for prevention of cataract |
JPH08134134A (ja) * | 1994-11-09 | 1996-05-28 | Nippon Shokubai Co Ltd | 粒子状含水ゲル重合体の乾燥方法 |
JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
TW434023B (en) * | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
JPH0995413A (ja) * | 1995-09-29 | 1997-04-08 | Shiseido Co Ltd | 皮膚外用剤 |
GB9718568D0 (en) * | 1997-09-03 | 1997-11-05 | Chauvin Pharmaceuticals Limite | Compositions |
WO2000004916A1 (en) * | 1998-07-23 | 2000-02-03 | Societe De Conseils De Recherches Et D'applications Scientifiques Sas | Encapsulation of water soluble peptides |
CA2328092A1 (en) * | 1999-01-12 | 2000-07-20 | Vito-Mannan Polysaccharide L.L.C. | Method of isolating mucilaginous polysaccharides and uses thereof |
JP2001318350A (ja) * | 2000-05-11 | 2001-11-16 | Lion Corp | コンタクトレンズ用溶液 |
MXPA02011254A (es) * | 2000-05-15 | 2003-03-10 | Procter & Gamble | Composiciones que comprenden ciclodextrina. |
US20020147232A1 (en) * | 2000-05-26 | 2002-10-10 | Claus Sundgreen | Pharmaceutical compositions comprising desglymidodrine as an active drug substance |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
US6541510B2 (en) * | 2000-09-28 | 2003-04-01 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
-
2003
- 2003-04-17 RU RU2004133887/04A patent/RU2321597C2/ru not_active IP Right Cessation
- 2003-04-17 EP EP03720497A patent/EP1499361B1/en not_active Expired - Lifetime
- 2003-04-17 WO PCT/EP2003/004076 patent/WO2003089008A1/en active Application Filing
- 2003-04-17 CN CN038088592A patent/CN1646171B/zh not_active Expired - Fee Related
- 2003-04-17 KR KR1020047016698A patent/KR101121675B1/ko not_active IP Right Cessation
- 2003-04-17 JP JP2003585759A patent/JP4648632B2/ja not_active Expired - Fee Related
- 2003-04-17 US US10/511,075 patent/US20050163853A1/en not_active Abandoned
- 2003-04-17 PT PT03720497T patent/PT1499361E/pt unknown
- 2003-04-17 NZ NZ535810A patent/NZ535810A/en not_active IP Right Cessation
- 2003-04-17 ES ES03720497T patent/ES2392964T3/es not_active Expired - Lifetime
- 2003-04-17 CA CA2484100A patent/CA2484100C/en not_active Expired - Fee Related
- 2003-04-17 PL PL371595A patent/PL215579B1/pl unknown
- 2003-04-17 MX MXPA04010325A patent/MXPA04010325A/es active IP Right Grant
- 2003-04-17 AU AU2003224099A patent/AU2003224099B2/en not_active Ceased
- 2003-04-17 BR BR0309340-9A patent/BR0309340A/pt not_active IP Right Cessation
-
2004
- 2004-09-28 ZA ZA200407794A patent/ZA200407794B/xx unknown
- 2004-10-14 IL IL164627A patent/IL164627A/en not_active IP Right Cessation
- 2004-10-26 CO CO04107397A patent/CO5611168A2/es active IP Right Grant
- 2004-11-16 NO NO20044979A patent/NO20044979L/no not_active Application Discontinuation
-
2005
- 2005-07-07 HK HK05105740.7A patent/HK1073070A1/xx unknown
-
2008
- 2008-07-24 US US12/178,934 patent/US20080299166A1/en not_active Abandoned
-
2011
- 2011-10-25 US US13/281,033 patent/US20120040901A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL215579B1 (pl) | 2013-12-31 |
NZ535810A (en) | 2007-11-30 |
CN1646171A (zh) | 2005-07-27 |
HK1073070A1 (en) | 2005-09-23 |
EP1499361B1 (en) | 2012-08-08 |
EP1499361A1 (en) | 2005-01-26 |
KR20040103968A (ko) | 2004-12-09 |
ES2392964T3 (es) | 2012-12-17 |
CA2484100A1 (en) | 2003-10-30 |
CA2484100C (en) | 2012-01-03 |
MXPA04010325A (es) | 2005-06-08 |
PT1499361E (pt) | 2012-11-22 |
AU2003224099B2 (en) | 2006-11-09 |
PL371595A1 (en) | 2005-06-27 |
WO2003089008A1 (en) | 2003-10-30 |
AU2003224099A1 (en) | 2003-11-03 |
CN1646171B (zh) | 2010-05-26 |
JP4648632B2 (ja) | 2011-03-09 |
ZA200407794B (en) | 2006-02-22 |
IL164627A0 (en) | 2005-12-18 |
RU2004133887A (ru) | 2005-10-20 |
BR0309340A (pt) | 2005-03-08 |
IL164627A (en) | 2009-11-18 |
US20120040901A1 (en) | 2012-02-16 |
US20080299166A1 (en) | 2008-12-04 |
CO5611168A2 (es) | 2006-02-28 |
US20050163853A1 (en) | 2005-07-28 |
JP2005529879A (ja) | 2005-10-06 |
RU2321597C2 (ru) | 2008-04-10 |
KR101121675B1 (ko) | 2012-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20044979L (no) | Nye biomaterialer, deres fremstilling og anvendelse | |
BRPI0418622A (pt) | plantas auto-processantes e partes de planta | |
BR0313226A (pt) | Uso de agentes de floculação para separar resìduo sólido em substratos de fermentação hidrolisados | |
Rente et al. | Review of deep eutectic systems from laboratory to industry, taking the application in the cosmetics industry as an example | |
WO2005061672A3 (en) | Method of decomposition polymer | |
BR0212654A (pt) | Ativação e expansão de células | |
BR9813968A (pt) | Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa | |
BR0211028A (pt) | Solução aquosa, método para formação de associações de fármaco e polìmero, composições farmacêuticas, método para formação de uma composição farmacêutica e produto | |
ATE349407T1 (de) | Zusammensetzungen, die ionische flüssigkeiten enthalten, und deren vewendungen, insbesondere in der organischen synthese | |
DE1149116T1 (de) | Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten | |
WO2008021574A8 (en) | Modulating plant carotenoid levels | |
NO20034853D0 (no) | Fargestoffer innkapslet i en polymermatrise | |
AU2003234956A1 (en) | Pesticidal pyridinecarboxamide derivatives | |
WO2009134996A3 (en) | Method of conditioning a mixed liquor containing nonionic polysaccharides and/or nonionic organic molecules | |
BR9803727A (pt) | Tintas biostáveis de base em água e processo para suas preparações. | |
Rios et al. | Pyruvate aldol condensation product: a metabolite that escaped synthetic preparation for over a century | |
Hainal et al. | Lignin as a carbon source for the cultivation of some Rhodotorula species | |
Kim et al. | Geopolymerization of biopolymers: a preliminary inquiry | |
JP2008072961A (ja) | 高分子タンニンの酵素的架橋反応 | |
AU7250601A (en) | Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes | |
AU2003263914A1 (en) | Rosin-fatty acid vinylic polymer compositions | |
Usharani et al. | Stabilization of collagen through bioconversion: An insight in protein–protein interaction | |
BR0115242A (pt) | Processo para a preparação de uma resina alquìdica modificada por acrìlico, resina alquìdica modificada por acrìlico, processo para a preparação de uma composição de resina alquìdica modificada por acrìlico transportada por água, e, composições de resina alquìdica modificada por acrìlico transportada por água, e de revestimento | |
CN103880139A (zh) | 一种天然高分子絮凝剂及其制备方法 | |
Zhao et al. | Preparation and Investigation of a Fully Biobased Adhesive Composed of Gum Arabic and Soy Protein Isolate for Plywood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |